Nikoletta Lendvai, Ph.D.
Affiliations: | 2000 | Yeshiva University, New York, NY, United States |
Area:
Immunology, Microbiology BiologyGoogle:
"Nikoletta Lendvai"Parents
Sign in to add mentor| Arturo Casadevall | grad student | 2000 | Yeshiva University | |
| (Effect of immune complexes of Cryptococcus neoformans polysaccharide on the host.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trudel S, Lendvai N, Popat R, et al. (2018) Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. The Lancet. Oncology |
| Murata K, McCash SI, Carroll B, et al. (2016) Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood. Clinical Biochemistry |
| Westin Kwon K, Lendvai N, Morrison S, et al. (2002) Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide. Clinical and Diagnostic Laboratory Immunology. 9: 201-4 |
| Lendvai N, Qu XW, Hsueh W, et al. (2000) Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. Journal of Immunology (Baltimore, Md. : 1950). 164: 4367-74 |
| Glatman-Freedman A, Mednick AJ, Lendvai N, et al. (2000) Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infection and Immunity. 68: 335-41 |
| Lendvai N, Casadevall A. (1999) Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype. The Journal of Infectious Diseases. 180: 791-801 |
| Casadevall A, Cleare W, Feldmesser M, et al. (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrobial Agents and Chemotherapy. 42: 1437-46 |
| Lendvai N, Casadevall A, Liang Z, et al. (1998) Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. The Journal of Infectious Diseases. 177: 1647-59 |
| Lendvai N, Casadevall A, Liang Z, et al. (1997) Effect of humoral immune mechanisms on the pharmacokinetics, organ distribution and tissue localization of an immunologically active fungal polysaccharide antigen Clinical Infectious Diseases. 25: 386 |